These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 21929317)

  • 1. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy-induced salivary dysfunction.
    Ship JA; Hu K
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):29-36. PubMed ID: 15726520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced xerostomia in patients with head and neck cancer: a literature review.
    Dirix P; Nuyts S; Van den Bogaert W
    Cancer; 2006 Dec; 107(11):2525-34. PubMed ID: 17078052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
    de Castro G; Federico MH
    Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Xerostomia caused by radiotherapy of patients with head and neck cancer].
    Bentzen JK
    Ugeskr Laeger; 1992 Jan; 154(3):126-9. PubMed ID: 1738952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of radiation-induced xerostomia.
    Berk LB; Shivnani AT; Small W
    J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
    Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
    Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer.
    Rieger JM; Jha N; Lam Tang JA; Harris J; Seikaly H
    Head Neck; 2012 Feb; 34(2):168-74. PubMed ID: 21416547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of prevention and management of radiation-induced xerostomia].
    Ma DY; Qiu WL; Zhang CP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):121-3. PubMed ID: 20368009
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
    Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia prevention after head and neck cancer treatment.
    Seikaly H
    Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.